Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Wild

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Lipids|March 26, 2002
Locally and systemically active glucocorticosteroids modify intestinal absorption of lipids in ratsA Thiesen, G E Wild, M Keelan, et al.
Gut|August 13, 2003
Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating studyS Nikolaus, P Rutgeerts, R Fedorak, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 4, 2007
Oral polyamine administration modifies the ontogeny of hexose transporter gene expression in the postnatal rat intestineG E Wild, L E Searles, K G Koski, et al.
The American Journal of Gastroenterology|June 1, 1996
Detection of Helicobacter pylori infection by saliva IgG testingC A Fallone, M Elizov, P Cleland, et al.
The American Journal of Gastroenterology|May 26, 2001
Psychological distress, social support, and disease activity in patients with inflammatory bowel diseaseM J Sewitch, M Abrahamowicz, A Bitton, et al.
Gut|January 14, 2003
The locally acting glucocorticosteroid budesonide enhances intestinal sugar uptake following intestinal resection in ratsA Thiesen, G E Wild, K A Tappenden, et al.
Gut|April 9, 2008
Predicting relapse in Crohn's disease: a biopsychosocial modelA Bitton, P L Dobkin, M D Edwardes, et al.
Digestion|November 13, 2002
Intestinal resection- and steroid-associated alterations in gene expression were not accompanied by changes in lipid uptakeA Thiesen, G E Wild, K A Tappenden, et al.
Gut|April 11, 2006
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trialG Van Assche, W J Sandborn, B G Feagan, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Lipids|March 26, 2002
Locally and systemically active glucocorticosteroids modify intestinal absorption of lipids in ratsA Thiesen, G E Wild, M Keelan, et al.
Gut|August 13, 2003
Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating studyS Nikolaus, P Rutgeerts, R Fedorak, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 4, 2007
Oral polyamine administration modifies the ontogeny of hexose transporter gene expression in the postnatal rat intestineG E Wild, L E Searles, K G Koski, et al.
The American Journal of Gastroenterology|June 1, 1996
Detection of Helicobacter pylori infection by saliva IgG testingC A Fallone, M Elizov, P Cleland, et al.
The American Journal of Gastroenterology|May 26, 2001
Psychological distress, social support, and disease activity in patients with inflammatory bowel diseaseM J Sewitch, M Abrahamowicz, A Bitton, et al.
Gut|January 14, 2003
The locally acting glucocorticosteroid budesonide enhances intestinal sugar uptake following intestinal resection in ratsA Thiesen, G E Wild, K A Tappenden, et al.
Gut|April 9, 2008
Predicting relapse in Crohn's disease: a biopsychosocial modelA Bitton, P L Dobkin, M D Edwardes, et al.
Digestion|November 13, 2002
Intestinal resection- and steroid-associated alterations in gene expression were not accompanied by changes in lipid uptakeA Thiesen, G E Wild, K A Tappenden, et al.
Gut|April 11, 2006
Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trialG Van Assche, W J Sandborn, B G Feagan, et al.
Pageof 3